On January 1, 21 drugs in the HRSA Rebate Model Pilot move from an upfront 340B discount to a rebate paid through Beacon. Whether those rebates reach you on time depends on steps your organization takes before then.
Our October 14 post covered what the 10 approved manufacturer plans say. This guide covers what to do about them, one question at a time. Your NuvemRx team is here to help with each step.
Confirm your documents in Beacon, and submit new bank letters where required.
Get 100% of the pharmacies in your network registered and active in 340B ESP by December 15.
Clear your accumulators of in-scope drugs.
The rebate model moves your 340B savings from the day you buy to the day Beacon pays. These steps keep that money arriving in time to fund the care it was always meant to pay for.
We're 100% dedicated to safety-net providers, with zero confirmed HRSA audit findings in 10+ years across all of NuvemRx.
Working with a NuvemRx Client Success Manager? Your CSM will work with you on every item above. Questions? Contact your CSM.
Not yet a client? Start a conversation below.
Bookmark this link for continually updated resources and insights to help pharmacy become the engine that drives expanded care for your community.
This article is general information for 340B covered entities and is not legal, tax, accounting, or financial advice. It reflects HRSA’s 340B Rebate Model Pilot Program, Beacon’s 340B Rebate platform requirements, and approved manufacturer 340B Rebate policies as of October 23, 2026. Pilot timing, manufacturer requirements (including bank letters, 340B ESP registration, and MFP handling), and Beacon processes may change; check each manufacturer’s current policy on Beacon before acting. The NuvemRx services described depend on your arrangement: claim submission and rebate reporting apply when NuvemRx is your TPA, and denial management applies when NuvemRx is also your pharmacy manager. NuvemRx figures (100% dedicated to safety-net providers, zero confirmed HRSA audit findings in 10+ years) are company-wide and span all NuvemRx solutions. Audit and duplicate discount statements are general; whether a particular claim is rebate-eligible depends on your own program configuration and compliance review. Consult your own advisors, and confirm the requirements that apply to your organization.